InsiderTradesSIGMA

InsidersTradesSigma

Unknown · Dirigeant — reported transactions · 113 filings

← Executives ★ Sign in to follow

U

Unknown

Dirigeant

Other

DK·Finanstilsynet DK

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the detailed record of transactions filed by Unknown, Dirigeant. Insider active across 1 companies, notably Genmab A/S. Aggregated, 113 disclosures have been logged. The latest transaction was disclosed on 2 March 2026 — Other. Regulator: Finanstilsynet DK. All data is openly available.

Declarations113 total

Executives●OtherGGenmab A/S11DK FSA

U

DKK 16 shares@ DKK 0.24090.0000% mcap100.0% of flow

ShareOutside the market

DK:1423836·2 Mar 2026

Executives●OtherGGenmab A/S3DK FSA

U

0567 shares0

ShareOutside the market

DK:1423824·2 Mar 2026

Executives●GrantGGenmab A/S3DK FSA

U

033,293 shares0

ShareOutside the market

DK:1423440·27 Feb 2026

Executives●SaleGGenmab A/S5DK FSA

U

€217,775899 shares@ €242.24140.0002% mcap0.5% of flow

ShareXCSE

DK:1421715·19 Feb 2026

Executives●OtherGGenmab A/S5DK FSA

U

€103,390378 shares@ €273.51890.0001% mcap0.2% of flow

ShareOutside a market place

DK:1403941·1 Dec 2025

Executives●SaleGGenmab A/S5DK FSA

U

€11,02442 shares@ €262.47960.0000% mcap0.0% of flow

ShareAQEU

DK:1401641·19 Nov 2025

Executives●SubscriptionGGenmab A/S6DK FSA

U

€3m23,266 shares@ €137.29050.0026% mcap7.3% of flow

ShareOutside the market

DK:1387733·9 Sept 2025

Executives●SaleGGenmab A/S5DK FSA

U

€4,77824 shares@ €199.09840.0000% mcap0.0% of flow

ShareXCSE

DK:1371150·17 Jun 2025

Executives●OtherGGenmab A/S5DK FSA

U

0996 shares0

ShareOutside a market place

DK:1352989·1 Apr 2025

Executives●SubscriptionGGenmab A/S6DK FSA

U

€3m24,461 shares@ €138.28280.0027% mcap7.7% of flow

ShareOutside the market

DK:1310577·13 Aug 2024

Executives●SaleGGenmab A/S5DK FSA

U

€1,5396 shares@ €256.57940.0000% mcap0.0% of flow

ShareAQEU

DK:1301181·10 Jun 2024

Executives●GrantGGenmab A/S5DK FSA

U

0837 shares0

ShareOutside the market

DK:1280998·13 Mar 2024

Executives●PurchaseGGenmab A/S5DK FSA

U

€26,0917,000 shares@ €3.72730.0000% mcap0.1% of flow

ShareXNAS

DK:1279104·28 Feb 2024

Ideal exit: 24 Nov 2024 (T+270)

Executives●OtherGGenmab A/S5DK FSA

U

05,630 shares0

ShareOutside a market place

DK:1278822·1 Mar 2024

Executives●SaleGGenmab A/S6DK FSA

U

€3m11,299 shares@ €260.60360.0024% mcap6.7% of flow

ShareAquis Exchange (AQEA, AQED, AQEU)

DK:1278470·28 Feb 2024

Executives●SubscriptionGGenmab A/S5DK FSA

U

€707,6425,147 shares@ €137.48630.0006% mcap1.6% of flow

ShareOutside the market

DK:1277786·27 Feb 2024

Executives●GrantGGenmab A/S5DK FSA

U

027,404 shares0

ShareOutside the market

DK:1277173·23 Feb 2024

Executives●OtherGGenmab A/S5DK FSA

U

0335 shares0

ShareOutside a market place

DK:1267553·2 Jan 2024

Executives●GrantGGenmab A/S5DK FSA

U

0559 shares0

ShareOutside the market

DK:1260557·21 Nov 2023

Executives●SaleGGenmab A/S5DK FSA

U

€3,66010 shares@ €366.00090.0000% mcap0.0% of flow

ShareXCSE

DK:1231690·1 Jun 2023

Executives●SaleGGenmab A/S5DK FSA

U

€23,57964 shares@ €368.42590.0000% mcap0.1% of flow

ShareAquis Exchange Europe (AQEA, AQED and AQEU)

DK:1231273·30 May 2023

Executives●PurchaseGGenmab A/S5DK FSA

U

€15,656300 shares@ €52.18570.0000% mcap0.0% of flow

ShareOTCM

DK:1219047·6 Apr 2023

Ideal exit: 1 Jan 2024 (T+270)

Executives●OtherGGenmab A/S5DK FSA

U

0981 shares0

ShareOutside a market place

DK:1218022·3 Apr 2023

Executives●GrantGGenmab A/S5DK FSA

U

020,049 shares0

ShareOutside the market

DK:1216690·29 Mar 2023

Executives●GrantGGenmab A/S5DK FSA

U

01,122 shares0

ShareTransactions with Shares and Linked Securities in Genmab A/S Made by

DK:1209538·24 Feb 2023

25 of 113 declarations

About Unknown

This insider is associated with Genmab A/S, a biopharmaceutical company. While their role is not specified, it is likely that they hold an executive position. Genmab A/S is known for its innovative oncology treatments, and this insider contributes to the management of the company.